Silexion Therapeutics LTD

NASDAQ: SLXNW · Real-Time Price · USD
0.07
0.00 (1.01%)
At close: Jun 09, 2025, 9:30 AM

Silexion Therapeutics LTD Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
n/a n/a n/a n/a
Cost of Revenue
n/a n/a n/a n/a
Gross Profit
n/a n/a n/a n/a
Operating Income
-12.57M -4.68M -3.86M -943.93K
Interest Income
n/a 153K 114K 6.37K
Pretax Income
16.51M -5.08M -3.46M -755.22K
Net Income
16.51M -4.94M -3.21M -755.22K
Selling & General & Admin
6.76M 928K 577K 943.93K
Research & Development
5.82M 3.71M 3.23M n/a
Other Expenses
n/a 45K 57K n/a
Operating Expenses
12.57M 4.68M 3.86M 943.93K
Interest Expense
n/a 9K 85K n/a
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
-12.57M 4.68M 3.86M -943.93K
Income Tax Expense
10K 32K 24K n/a
Shares Outstanding (Basic)
623.85K 681.09K 1.67M 1.65M
Shares Outstanding (Diluted)
623.85K 681.09K 1.67M 1.65M
EPS (Basic)
25.49 0.39 0.35 -0.46
EPS (Diluted)
25.49 0.39 0.35 -0.46
EBITDA
-16.43M -4.64M -3.8M -755.22K
EBIT
-16.46M -4.68M -3.86M -755.22K
Depreciation & Amortization
25K 45K 57K 188.72K